Biotechnology and Health Sciences

Published by: Kowsar

The Effect of Myricetin Flavonoid on the Expression of Fyn Gene in Melanoma Cells (A375)

Fereshte Abdolmaleki 1 , Sahar Moghbelinejad 2 and Hossein Ahmadpour-Yazdi 2 , *
Authors Information
1 Student Research Committee of Paramedical Sciences, Qazvin University of Medical Sciences, Qazvin, Iran
2 Cellular and Molecular Research Center, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
Article information
  • Biotechnology and Health Sciences: , 5 (1); e14484
  • Published Online: October 14, 2017
  • Article Type: Research Article
  • Received: June 3, 2017
  • Revised: July 25, 2017
  • Accepted: September 20, 2017
  • DOI: 10.5812/bhs.14484

To Cite: Abdolmaleki F, Moghbelinejad S, Ahmadpour-Yazdi H. The Effect of Myricetin Flavonoid on the Expression of Fyn Gene in Melanoma Cells (A375), Biotech Health Sci. Online ahead of Print ;5(1):e14484. doi: 10.5812/bhs.14484.

Copyright: Copyright © 2017, Biotechnology and Health Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Gandhi SA, Kampp J. Skin Cancer Epidemiology, Detection, and Management. Med Clin North Am. 2015; 99(6): 1323-35[DOI][PubMed]
  • 2. Jaime A, Remsberg CM, Takemoto JK, Vega-Villa KR, Andrews PK, Sayre CL, et al. Polyphenols and flavonoids : an overview. 2013;
  • 3. Pinheiro PF, Justino GC. Structural analysis of flavonoids and related compounds-a review of spectroscopic applications. 2012;
  • 4. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem. 2007; 18(7): 427-42[DOI][PubMed]
  • 5. Yao Y, Lin G, Xie Y, Ma P, Li G, Meng Q, et al. Preformulation studies of myricetin: a natural antioxidant flavonoid. Pharmazie. 2014; 69(1): 19-26[PubMed]
  • 6. Shih YW, Wu PF, Lee YC, Shi MD, Chiang TA. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway. J Agric Food Chem. 2009; 57(9): 3490-9[DOI][PubMed]
  • 7. Ying X, Chen X, Feng Y, Xu HZ, Chen H, Yu K, et al. Myricetin enhances osteogenic differentiation through the activation of canonical Wnt/beta-catenin signaling in human bone marrow stromal cells. Eur J Pharmacol. 2014; 738: 22-30[DOI][PubMed]
  • 8. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000; 6(4): 909-19[DOI][PubMed]
  • 9. Young MR, Yang HS, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med. 2003; 9(1): 36-41[DOI][PubMed]
  • 10. Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest. 2004; 114(5): 720-8[DOI][PubMed]
  • 11. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene. 2004; 23(48): 7918-27[DOI][PubMed]
  • 12. Čalić, M. , Jelić, D. , Antolović, R. , Nujić, K. , Marjanović, N. , Stupin Polančec, D. , et al. Flavonoids as inhibitors of lck and fyn kinases. Croat Chem Acta. 2005; 78(3): 367-74
  • 13. Posadas EM, Al-Ahmadie H, Robinson VL, Jagadeeswaran R, Otto K, Kasza KE, et al. FYN is overexpressed in human prostate cancer. BJU Int. 2009; 103(2): 171-7[DOI][PubMed]
  • 14. Chen R, Kim O, Yang J, Sato K, Eisenmann KM, McCarthy J, et al. Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem. 2001; 276(34): 31858-62[DOI][PubMed]
  • 15. Liao Y, Grobholz R, Abel U, Trojan L, Michel MS, Angel P, et al. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer. Int J Cancer. 2003; 107(4): 676-80[DOI][PubMed]
  • 16. Vernon AE, LaBonne C. Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol. 2004; 14(17)-21[DOI][PubMed]
  • 17. Abdolmaleki F, Gheibi N, Ahmadpour_ Yazdi H. The inhibitory effect of myricetin in melanoma cells (A375). Novelty Biomed. 2017; 5(3): 104-8
  • 18. Pfaffl MW. A-Z of Quantitative PCR 2004;
  • 19. Gajos-Michniewicz A, Czyz M. Modulation of WNT/beta-catenin pathway in melanoma by biologically active components derived from plants. Fitoterapia. 2016; 109: 283-92[DOI][PubMed]
  • 20. Yadav V, Denning MF. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog. 2011; 50(5): 346-52[DOI][PubMed]
  • 21. Zhang X, Li F, Zhu PL. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion. Biomed Pharmacother. 2016; 84: 270-6[DOI][PubMed]
  • 22. Berwanger B, Hartmann O, Bergmann E, Bernard S, Nielsen D, Krause M, et al. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell. 2002; 2(5): 377-86[DOI][PubMed]
  • 23. Chen JS, Hung WS, Chan HH, Tsai SJ, Sun HS. In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma. Bioinformatics. 2013; 29(4): 420-7[DOI][PubMed]
  • 24. Goel RK, Lukong KE. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology. Cancer Metastasis Rev. 2016; 35(2): 179-99[DOI][PubMed]
  • 25. Devi KP, Rajavel T, Habtemariam S, Nabavi SF, Nabavi SM. Molecular mechanisms underlying anticancer effects of myricetin. Life Sci. 2015; 142: 19-25[DOI][PubMed]
  • 26. Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, Heo YS, et al. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res. 2008; 68(14): 6021-9[DOI][PubMed]
  • 27. Li Y, Cui SX, Sun SY, Shi WN, Song ZY, Wang SQ, et al. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice. Oncotarget. 2016; 7(37): 60446-60[DOI][PubMed]
  • 28. Huang H, Chen AY, Ye X, Li B, Rojanasakul Y, Rankin GO, et al. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway. Int J Oncol. 2015; 47(4): 1494-502[DOI][PubMed]
  • 29. Bagu ET, Miah S, Dai C, Spriggs T, Ogunbolude Y, Beaton E, et al. Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation. Oncotarget. 2017; 8(7): 11442-59[DOI][PubMed]
  • 30. Hou DX, Kumamoto T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid Redox Signal. 2010; 13(5): 691-719[DOI][PubMed]
  • 31. Bogoyevitch MA, Fairlie DP. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. Drug Discov Today. 2007; 12(15-16): 622-33[DOI][PubMed]
  • 32. McCubrey JA, Rakus D, Gizak A, Steelman LS, Abrams SL, Lertpiriyapong K, et al. Effects of mutations in Wnt/beta-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer. Biochim Biophys Acta. 2016; 1863(12): 2942-76[DOI][PubMed]
  • 33. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127(3): 469-80[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader